Buy Emami; target of Rs 670: Sharekhan

Buy

Sharekhan's research report on Emami

Emami’s Q3FY25 performance was better compared to peers with a 6% y-o-y domestic volume growth. Revenue and adjusted PAT grew by 5% y-o-y each. Consolidated OPM at 32.3%, came in higher than expectation of 31.6%. Management expects double-digit growth momentum in BoroPlus and Healthcare range to continue in Q4. Kesh King would see new strategies being announced in 1-2 quarters.Rebranding of Fair & Handsome (as Smart & Handsome), recovery in Kesh King and improved international performance will support growth in the coming years.

Outlook

Stock trades at 28x/25x/22x its FY25E/26E/27E EPS, respectively, which is a discount to its five-year average multiple. We maintain a Buy with a revised PT of Rs. 670.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Emami_29012025_Sharekhan